NCT00518141

Brief Summary

This study aims to determine the possible effects of Acetyl Salicylic Acid (ASA) and Terbutalin on ART treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2006

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2006

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

August 17, 2007

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 20, 2007

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2009

Completed
Last Updated

July 21, 2011

Status Verified

July 1, 2011

Enrollment Period

3.2 years

First QC Date

August 17, 2007

Last Update Submit

July 20, 2011

Conditions

Reproductive Techniques, Assisted

Outcome Measures

Primary Outcomes (1)

  • Pregnancy

    7 weeks

Study Arms (6)

1

EXPERIMENTAL

FER

Drug: Acetyl Salicylic Acid and Terbutalin

2

NO INTERVENTION

FER

3

EXPERIMENTAL

SET

Drug: Acetyl Salicylic Acid and Terbutalin

4

NO INTERVENTION

SET

5

EXPERIMENTAL

DET

Drug: Acetyl Salicylic Acid and Terbutalin

6

NO INTERVENTION

DET

Interventions

Acetyl Salicylic Acid and TerbutalinDRUG

ASA 75 mg, Terbutalin 5mg

135

Eligibility Criteria

Age18 Years - 39 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Infertile women below 39 years of age

You may not qualify if:

  • Women who may react allergically to the drugs administered
  • Women with hyperthyroid or IDDM
  • Women who do not want to participate in the study
  • Women who are unable to give informed, written consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

STHF, Kvinneklinikken, Fertilitetsklinikken Sor

Porsgrunn, Telemark, 3901, Norway

Location

MeSH Terms

Conditions

Helping Behavior

Interventions

Terbutaline

Condition Hierarchy (Ancestors)

Social BehaviorBehavior

Intervention Hierarchy (Ancestors)

EthanolaminesAmino AlcoholsAlcoholsOrganic ChemicalsAmines

Study Officials

  • Jarl A Kahn, Dr. med

    STHF, Kvinneklinikken, Fertilitetsklinikken Sor

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV

Study Record Dates

First Submitted

August 17, 2007

First Posted

August 20, 2007

Study Start

March 1, 2006

Primary Completion

May 1, 2009

Study Completion

May 1, 2009

Last Updated

July 21, 2011

Record last verified: 2011-07

Locations

NO(1)